WASHINGTON, Jan. 25, 2024 /PRNewswire/ Vanda Pharmaceuticals Inc. today announced the publication of an article titled The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic.
Vanda Pharmaceuticals Inc. (Vanda) today announced the publication of an article titled "The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in Phase III Randomized Placebo-Controlled Clinical Trial" in the Clinical.